Related Experiment Video

Updated: Feb 10, 2026

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

1.1K

[Bronchopulmonary infection in cystic fibrosis]

Anne Munck1, Edouard Bingen

  • 1Service de gastro-entérologie, Hôpital Robert-Debré 75019 Paris. anne.munck@rdb.ap-hop-paris.fr

La Revue Du Praticien
|April 1, 2003
PubMed

Insights

Cystic fibrosis patients face severe lung infections, primarily from Staphylococcus aureus and Pseudomonas aeruginosa. Early antibiotic treatment and long-term strategies are crucial for managing infections, improving survival, and enhancing quality of life.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Context:

  • Cystic fibrosis (CF) patients have a vital prognosis determined by bronchopulmonary infections.
  • Staphylococcus aureus infection often precedes Pseudomonas aeruginosa colonization, a key factor in CF lung deterioration.

Purpose:

  • To outline strategies for managing bacterial infections in cystic fibrosis patients.
  • To emphasize the importance of timely antibiotic interventions for preventing chronic colonization and antimicrobial resistance.

Summary:

  • Intensive antibiotic treatment during initial Staphylococcus aureus infection can prevent or delay Pseudomonas aeruginosa colonization.
  • Chronic Pseudomonas aeruginosa colonization requires a long-term antibiotic strategy, with treatments administered every 3-4 months to prevent exacerbations and the emergence of multidrug-resistant organisms.
  • A comprehensive management approach combining antibiotherapy, physiotherapy, and nutritional support is essential.

Impact:

  • Effective management of bacterial infections significantly improves survival rates and quality of life for cystic fibrosis patients.
  • Preventing chronic colonization and antimicrobial resistance is critical for long-term patient health outcomes.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.2K
Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.0K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
891
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
547
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
12.7K
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
65.4K
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
9.8K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.2K